每經AI快訊，博(bo)瑞醫(yi)藥(yao)公(gong)告，近日收到公(gong)司控股(gu)(gu)(gu)股(gu)(gu)(gu)東、實(shi)際(ji)(ji)控制人(ren)(ren)(ren)袁建(jian)棟、實(shi)際(ji)(ji)控制人(ren)(ren)(ren)鐘(zhong)偉芳及(ji)其一(yi)致行(xing)動(dong)人(ren)(ren)(ren)蘇州博(bo)瑞鑫穩(wen)管理咨詢合伙企業（有(you)限合伙）出具的《關(guan)于(yu)不(bu)減(jian)持(chi)公(gong)司股(gu)(gu)(gu)份的承(cheng)(cheng)(cheng)諾(nuo)函》，公(gong)司控股(gu)(gu)(gu)股(gu)(gu)(gu)東、實(shi)際(ji)(ji)控制人(ren)(ren)(ren)袁建(jian)棟、實(shi)際(ji)(ji)控制人(ren)(ren)(ren)鐘(zhong)偉芳及(ji)其一(yi)致行(xing)動(dong)人(ren)(ren)(ren)博(bo)瑞鑫穩(wen)分別自愿承(cheng)(cheng)(cheng)諾(nuo)自本承(cheng)(cheng)(cheng)諾(nuo)函出具之日起未(wei)來6個月內（即(ji)2023年12月7日至2024年6月6日）不(bu)以(yi)任何方式減(jian)持(chi)其持(chi)有(you)的公(gong)司股(gu)(gu)(gu)份。在(zai)上述承(cheng)(cheng)(cheng)諾(nuo)期間內，如發(fa)生資(zi)本公(gong)積轉增(zeng)股(gu)(gu)(gu)本、派(pai)送股(gu)(gu)(gu)票紅利、配股(gu)(gu)(gu)等產生新增(zeng)股(gu)(gu)(gu)份，亦遵守該不(bu)減(jian)持(chi)承(cheng)(cheng)(cheng)諾(nuo)。